BioWorld MedTech

Dec. 4, 2012

Supreme Court limits scope of review of Myriad to eligibility

The Supreme Court has opted to take the Myriad gene patent case, the outcome of which could fundamentally alter how life science companies draft patents for inventions involving genetic materials. Read More

Financings roundup: NanoString completes $15.3M Series E preferred issuance

NeuroMetrix wins FDA clearance for Sensus pain management system

Washington roundup: CMS eyes coverage review for dozens of products, procedures

Report from Europe: Cytomedix reports CE mark appoval for Angel cPRP system

Deals roundup: Volcano to acquire Crux for $36 million in cash

Agreements/contracts: Clinigence combines analytics with Spring Medical Systems

Med-Tech Notes

People in the News

Product Briefs

MDD's Cardio Extra

Today's news in brief

BioWorld

BioWorld briefs for June 18, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 16, 2026

mRNA vaccines are composed of messenger RNA encapsulated in lipid nanoparticles

mRNA flu vaccine can activate broad germinal center response

BioWorld

On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...

GLP-1s need technologies for long-term use

BioWorld

For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...

UTRN gene involved in arthrogryposis, study finds

BioWorld Science

Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...